Why the study?
Associations between D-dimer and outcomes in ACS remain controversial, and whether age-adjusted D-dimer cutoff thresholds provide prognostic value after PCI was unknown.
Does an age-adjusted D-dimer elevation predict adverse outcomes in patients with acute coronary syndrome treated by percutaneous coronary intervention?
Does an age-adjusted D-dimer elevation predict adverse outcomes in patients with acute coronary syndrome treated by percutaneous coronary intervention?
Age-adjusted D-dimer thresholds significantly improve risk prediction for long-term mortality in ACS patients undergoing PCI.
Answers are grounded in this paper and cite their sources.
Should not yet change post-PCI ACS risk assessment; leaves open prospective validation of incremental prognostic value.
Background: Associations between D-dimer and outcomes of patients with acute coronary syndrome (ACS) remain controversial. Using age-adjusted D-dimer cutoff thresholds improve the diagnostic accuracy for thrombotic diseases. This study aimed to investigate the prognostic value of age-adjusted D-dimer in ACS patients treated by percutaneous coronary intervention (PCI). Methods: A total of 3972 consecutive patients with ACS treated by PCI were retrospectively recruited. The basal age-adjusted D-dimer threshold was 500 ng/mL and was calculated as age × 10 in patients older than 50 years. Cox regression was used for outcome analysis. C-index, net reclassification index (NRI), and integrated discrimination improvement (IDI) were calculated to assess the additional prognostic value of age-adjusted D-dimer when combined with established clinical risk factors. The primary outcome was all-cause death. Results: During a median follow-up of 720 days, a total of 225 deaths occurred. High D-dimer level, as defined by age-adjusted thresholds, was an independent predictor for all-cause death (hazard ratio [HR]: 1.75, 95% confidence interval [CI]: 1.32– 2.31, P < 0.001), cardiac death (HR: 1.84, 95% CI: 1.30– 2.60, P = 0.001), and MACE (HR: 1.48, 95% CI: 1.19– 1.83, P < 0.001). Sensitivity and subgroup analysis showed that high D-dimer levels were constantly associated with worse outcomes across common risk factors and comorbidities. Besides, age-adjusted elevation of D-dimer significantly improved the risk predictions for all-cause death when added to the model of established risk factors (C-index: 0.846 vs 0.838, Δ C-index: 0.008, 95% CI: 0.001– 0.015, P difference = 0.027; NRI: 0.645, 95% CI: 0.464– 0.826, P < 0.001; IDI: 0.008, 95% CI: 0.001– 0.017, P = 0.048). Conclusion: In ACS patients treated by PCI, age-adjusted elevation of D-dimer was an independent predictor for adverse outcomes and improved the risk predictions for long-term mortality.
No takes yet. Share an insight, caveat, or question.
A 2022 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: